Shay Shemesh
Förmögenhet: 33 M $ per 2026-06-30
Förmögenhet: 33 M $ per 2026-06-30
Shay Shemesh is the founder of Nuvectis Pharma, Inc., founded in 2020, holding the title of EVP, Chief Development & Operations Officer.
Former jobs include Head-Clinical Operations at Keryx Biopharmaceuticals, Inc. and Senior VP-Clinical & Regulatory Affairs at Stemline Therapeutics, Inc. from 2015 to 2020.
Education includes undergraduate and graduate degrees from Bar-Ilan University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 6,76 % | 2026-04-13 | 1 793 068 ( 6,76 % ) | 33 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| NUVECTIS PHARMA, INC. | Grundare | 2020-07-27 |
| Företag | Position | Slut |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-01-01 |
| KERYX BIOPHARMACEUTICALS | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån